Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The Termeer Foundation Expands Board of Directors


The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the expansion of its Board of Directors. The foundation added Gail Maderis, President and CEO of Antiva Biosciences; John Maraganore, CEO and Director at Alnylam Pharmaceuticals; and Joan Reede, M.D., Dean for Diversity and Community Partnership at Harvard Medical School to the board.

“We are honored to have Gail Maderis, John Maraganore and Joan Reede join The Termeer Foundation Board of Directors and help us advance our vision of connecting the world of healthcare innovators until every patient has a cure,” said Belinda Termeer, President and Co-Founder of The Termeer Foundation. “Their combined expertise spanning entrepreneurship, organizational leadership, mentoring, diversity and strategy will be instrumental in helping us build this foundation.”

Gail Maderis currently serves as President and CEO of Antiva Biosciences and as a member of the Board of Directors at Valitor Inc., the Biotechnology Innovation Organization (BIO), and the California Life Sciences Institute. She is also a Trustee of the University of California Berkeley Foundation. Gail has over 20 years of leadership experience in biopharmaceutical companies, including at Genzyme Corporation, where she worked closely with Henri Termeer. Previously, Gail led BayBio, the industry organization representing and supporting Northern California’s life science community. She also previously served as President and CEO of Five Prime Therapeutics, Inc., and held senior executive positions at Genzyme, including Founder and President of Genzyme Molecular Oncology (GZMO). Gail also practiced management and strategy consulting with Bain & Co. She received a BS in business from UC Berkeley and an MBA from Harvard Business School.

John Maraganore serves as CEO and Director at Alnylam Pharmaceuticals, Chair of the Board for Agios Pharmaceuticals, co-chair of the Termeer Tribute Committee, and member of the Biotechnology Industry Organization (BIO) Executive Committee. John brings The Termeer Foundation extensive experience gained from building and managing the translation of RNAi from a Nobel Prize-winning discovery into an innovative, entirely new class of medicines, and in the process creating one of the biopharmaceutical industry’s largest and arguably most successful companies. John has served as the CEO and a Director of Alnylam since 2002. Prior to Alnylam, John served as an officer and a member of the management team for Millennium Pharmaceuticals, and prior to that he held various positions at Biogen, where he invented and led the discovery and development of ANGIOMAX® (bivalirudin) for injection, formerly HIRULOG™ and currently marketed by The Medicines Company. Prior to Biogen, John was a scientist at ZymoGenetics, Inc., and the Upjohn Company. John also formerly served as Chair of the Board of Directors for the Biotechnology Innovation Organization (BIO). John received his MS and PhD in biochemistry and molecular biology at the University of Chicago.

Joan Reede, M.D., serves as Dean for Diversity and Community Partnership at Harvard Medical School, and President of the Biomedical Science Careers Program. Joan brings to The Termeer Foundation a lifelong passion for and experience with mentoring and supporting diversity in the biosciences. She is Harvard Medical School’s first Dean for Diversity and Community Partnership, responsible for the development and management of a comprehensive program that provides leadership, guidance, and support to promote the increased recruitment, retention, and advancement of underrepresented minority faculty. She also serves in a number of other positions, including Faculty Director of Community Outreach at HMS, Professor at HMS and at Harvard’s Chan School of Public Health, and Assistant in Health Policy at Massachusetts General Hospital. While at HMS, Joan created more than 20 diversity and leadership-focused programs, including founding the HMS Minority Faculty Development Program and the Biomedical Careers Program. Before joining Harvard, she served as the medical director of a Boston community health center and worked as a pediatrician in community and academic health centers, juvenile prisons, and public schools. She has held a number of advisory roles including serving on the Health and Human Services Advisory Committee on Minority Health and the Secretary’s Advisory Committee to the Director of NIH. Joan graduated from Brown University and Mount Sinai School of Medicine. She holds an MPH and an MS in Health Policy Management from Harvard T. H. Chan School of Public Health, and an MBA from Boston University.

Also joining The Termeer Foundation as a Board Observer is Adriana Termeer. The new appointees join existing board members Belinda Termeer and Alan Walts, Treasurer, Secretary, Mentor and Co-Founder of The Termeer Foundation and Venture Partner with Advent Life Sciences.

About The Termeer Foundation

Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation’s network of emerging and established healthcare innovators cultivates tomorrow’s leaders and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Visit us at http://www.termeerfoundation.org or on LinkedIn @TermeerFoundation.

Contact:

Paul Kidwell

Termeer Foundation

617-680-1088

paulkidwell@comcast.net

Share article on social media or email:

Ready, Set, Gold! Launches Enhanced Eight-Week Virtual Classroom Series featuring Top Olympians and Paralympians


Man on football field exercising

Paralympian Rudy Garcia-Tolson demonstrates the “Superman” for virtual fall series from Ready, Set, Gold!

“The guidance and encouragement offered by the Olympians and Paralympians will surely inspire students during these challenging times.” – David Ulich, GSD Executive Board Member

Ready, Set, Gold! today announced the launch of a new, eight-week digital classroom series designed to help kids stay active while distance learning from home. The series will be made available for free online to all students through the support of The Foundation for Global Sports Development and Sidewinder Films and will also feature standout Olympians and Paralympians, including gold medalists John Naber and Rudy Garcia-Tolson.

Leading social and emotional learning provider Classroom Champions will host the Fall Series through their customizable, intuitive online platform, putting resources, developed by Ready, Set, Gold!, at teachers’ fingertips. Each of the eight lessons will be released weekly on Monday, beginning October 12.

The 30-minute Virtual Ready, Set, Gold! lessons will give students the opportunity to exercise with a talented Olympian or Paralympian and learn a life lesson along the way. The series will teach students about a variety of topics that include the growth mindset, embracing challenges, healthy living and nutrition, perseverance, and self-awareness. Corresponding workouts will put these concepts into action.

“The virtual series provides a safe way for students to benefit at home from Ready, Set, Gold!,” said Michaela Reynolds, Program Director for Ready, Set, Gold!. “We are proud to partner with organizations like Classroom Champions and the YMCA of Metro LA to make these resources available to so many, and we plan to continue to use our virtual programming as a complement to our in-school programming when in-person classes resume.”

The Foundation for Global Sports Development and Sidewinder Films serve as long-time supporters of Ready, Set, Gold! and are a key sponsor for this innovative project.

David Ulich, GSD Executive Board Member agreed, stating, “I believe this program may be a lifeline for some young people. The guidance and encouragement offered by the Olympians and Paralympians will surely inspire students during these challenging times.”

In addition to the series’ availability on Classroom Champions, all lessons will also be made available specifically to students at the YMCA of Metro LA and at Ready, Set, Gold! partner schools in the Los Angeles Unified School District, the Claremont Unified School District, the Newport-Mesa Unified School District, the Snowline Joint Unified School District, and the Chula Vista School District.

The series will kick off with 2008 Olympic silver medalist and indoor volleyball player Kim Glass, who will cover the importance of gratitude with an endurance workout. Other athletes in the series include Olympic swimmers John Naber and John Moffet, who will head to the kitchen to talk nutrition and healthy living with students, and Paralympian gold medalist Rudy Garcia-Tolson, who will talk about goal-setting and focus on a strength-based workout.

The complete virtual series includes the following Olympians/Paralympians:

  • Anita Alvarez, Olympian – Artistic Swimming
  • Samantha Bosco, Paralympian – Cycling
  • Tasha Danvers, Olympian – Track and Field
  • Rudy Garcia-Tolson, Paralympian – Swimming, Track, and Triathlon
  • Kim Glass, Olympian – Indoor Volleyball
  • Kristy Kowal, Olympian – Swimming
  • John Moffet, Olympian – Swimming
  • John Naber, Olympian – Swimming
  • Alex Roelse, Olympian – Water Polo

To learn more about Ready, Set, Gold! visit http://www.readysetgold.net.

About Ready, Set, Gold!

Ready, Set, Gold! is a 501(c)(3) non-profit, community health and fitness program that promotes healthy and active lifestyles to children in Southern California schools. This one-of-a kind program launched in 2006 with the mission to promote fitness and life-long healthy habits by pairing Olympians and Paralympians with schools throughout Southern California. Ready, Set, Gold! Olympians and Paralympians work with students to educate them on the importance of the growth mindset while teaching them how them to adopt healthy habits into their daily lifestyle. Ready, Set, Gold! aims to help to students of all backgrounds, encouraging them to achieve their dreams and live their best life.

About Global Sports Development and Sidewinder Films

The Foundation for Global Sports Development and Sidewinder Films leverage the impact of philanthropy and the power of film to promote sportsmanship, education, fair play and ethics among the world’s youth. Giving special emphasis to groups and communities that are most in need or most underserved by current programs, the foundation strives to include women, minorities, and youth in its mission. The foundation’s media division, Sidewinder Films, supports this mission by producing groundbreaking documentaries that bring untold stories to the international community. Visit http://www.globalsportsdevelopment.org and http://www.sidewinderfilms.org to learn more.

Share article on social media or email:

How Regulators Are Sizing Up Evidence Today, Upcoming Webinar Hosted by Xtalks


The speakers will ground their predictions for the future in the historic response of regulatory bodies to epidemics, then explore recent shifts in the regulatory environment in response to COVID and the resulting new efficiencies in drug development.

In drug development, there is always pressure to move quickly, and with today’s push to develop treatments and vaccines for COVID, those pressures are exacerbated. From sponsors and investors to investigators and regulators, everyone is trying to balance the dual needs for speed and safety.

The places where they find success are likely to change drug development forever.

Adopting decentralized trials and embracing real-world data allows COVID (and other) trials to proceed at a time when typical site visits are fraught. Once global regulators are secure that even under these new circumstances, the data are still valid and clean, these processes are likely to be more widely implemented. In the meantime, sponsors should be confident about working closely with regulators to understand potentially shifting requirements and to build a strong regulatory strategy.

The speakers will ground their predictions for the future in the historic response of regulatory bodies to epidemics, then explore recent shifts in the regulatory environment in response to COVID and the resulting new efficiencies in drug development.

Join Linda McBride, Executive Director, Regulatory Affairs and Compliance Regulatory Professionals, a division of Premier Research and Vicki Gashwiler, Executive Director, Specialty Programs, Premier Research in a live webinar on Monday, October 26, 2020 at 11am EDT (3pm GMT/UK).

For more information or to register for this event, visit Speed vs. Safety: How Regulators Are Sizing Up Evidence Today.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Time for a Clinical Trial Revolution – Complex Innovative Design (CID) Cancer Trials, Upcoming Webinar Hosted by Xtalks


CID trials not only assess the safety and toxicity of novel anticancer medicines but also their efficacy in biomarker-selected patients, specific cancer cohorts or in combination with other agents.

This webinar will review a published consensus statement from the British Journal of Cancer (BJC), looking at recommendations for effective delivery of Complex Innovative Design (CID) cancer trials.

The traditional cancer drug development pathway is being superseded by trials that address multiple clinical questions. CID trials not only assess the safety and toxicity of novel anticancer medicines but also their efficacy in biomarker-selected patients, specific cancer cohorts or in combination with other agents. They can be adapted to include new cohorts and test additional agents within a single protocol. Whilst CID trials can speed up the traditional route to drug licensing, they can be challenging to design, conduct and interpret.

This webinar will cover:

  • The changing landscape of oncology drug development – safety, toxicity and efficacy in biomarker selected patient cohorts and other agents
  • Trial planning & design – stakeholder engagement, engagement with regulators
  • Protocol development & structure – identifying adaptations
  • Data & databases – defining the end of the trial
  • Risk assessment & monitoring – financial and operational, including source data verification
  • Trial management – the importance of compliance and communication in managing multiple cohorts from multiple parties
  • Statistical considerations – experience and flexibility


Join Sarah Blagden, Associate Professor of Medical Oncology, University of Oxford and Alain Thibault, Chairman, Simbec-Orion Oncology Advisory Board in a live webinar on Thursday, October 22, 2020 at 9am EDT (2pm BST/UK).

For more information or to register for this event, visit Time for a Clinical Trial Revolution – Complex Innovative Design (CID) Cancer Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

eHealth M&A Activity Increases in Q3:2020, According to Acquisition Data from HealthCareMandA.com


News Image

The Covid-19 epidemic hasn’t fazed investors in digital health companies. In fact, changes made to delivering health care since March have boosted interest in areas such as telehealth and remote patient monitoring.

eHealth merger and acquisition activity increased significantly in the third quarter of 2020, according to new acquisition data fromHealthCareMandA.com. There were 58 transactions were reported in the third quarter, a 17% increase compared with the previous quarter’s 51 deals. Deal volume was up a modest 2% compared with Q3:19 when 57 transactions were announced. Twenty-seven deals disclosed a price in the third quarter, totaling $20.8 billion, which eclipses the $606 million in announced spending for the second quarter. In Q3:19, the sector posted $9.56 billion in disclosed spending.

“The Covid-19 epidemic hasn’t fazed investors in digital health companies,” said Lisa E. Phillips, editor of the Health Care M&A Report, which publishes the data. “In fact, changes made to delivering health care since March have boosted interest in areas such as telehealth and remote patient monitoring.”

The largest deal in the sector was Teladoc Health, Inc.’s merger with Livongo Health, Inc. valued at $18.5 billion, creating a global leader in consumer-centered virtual care. Livongo, a leading Applied Health Signals company, uses its AI+AI engine and a team of data scientists to aggregate and interpret substantial amounts of health data and information to create actionable, personalized and timely health signals for its members.

Other notable deals include Warburg Pincus’ sale of Specialists On Call, Inc. (dba SOC Telemed) for $7.2 billion to Healthcare Merger Corp., a public investment vehicle, and the acquisition of DXC Technology’s healthcare software provider business for $5.25 billion by Dedalus Group, a portfolio company of the European-based private equity firm Ardian.

All quarterly results are published in The Health Care M&A Report, which is part of the HealthCareMandA.com investment research source. For sector-specific research and analysis, please see The 2020 Health Care Services Acquisition Report. For more information, or to order the reports, call 800-248-1668. Irving Levin Associates, Inc. was established in 1948 and has headquarters in New Canaan, Connecticut. The company publishes research reports and newsletters and maintains databases on the health care and senior housing M&A markets.

Share article on social media or email:

Crafting a Champion Out of an Athlete, Upcoming Webinar Hosted by Xtalks


In this webinar, the featured speakers will discuss and illustrate through case studies two disciplines of Aji Bio-Pharma’s Operational Excellence Journey program: visual controls and key performance indicators (KPIs), and continuous improvement.

Similar to developing an athlete into a champion, building a strong Operational Excellence foundation within a company starts with investing in a learning culture, which is then supported by people, driven by customer focus, and oriented towards continuous improvement.

To facilitate employee involvement and growth, Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, uses the Operational Excellence Journey to lead all departments (operational and non-operational) towards higher standards. This maturity matrix contains nine different disciplines in which development to the highest level can be pursued. Following the path, the departmental teams are motivated to progress along the journey with the goal of achieving Operational Excellence throughout the company.

In this webinar, the featured speakers will discuss and illustrate through case studies two disciplines of Aji Bio-Pharma’s Operational Excellence Journey program: visual controls and key performance indicators (KPIs), and continuous improvement.

Join the Ajinomoto Bio-Pharma Services US and Belgium Operational Excellence experts Bruno Flour, VP of Business Systems, IT & Operational Excellence EU, Melissa Rosness, MBA, Sr. Director of Operational Excellence & Training US, and Katrien Laurier, PhD Chemistry, Head of Operational Excellence EU, in a live webinar on Wednesday, October 28, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Operational Excellence: Crafting a Champion Out of an Athlete.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Nemours Children’s Health System Launches Precision Medicine Initiative


Clinical decision support provided by ActX will allow us to apply pharmacogenomic results alongside clinical information to arrive at the best medication and dose for the patient

Nemours Children’s Health System has added the ActX Genomic Decision Support system to its electronic health record (Epic), enabling the use of genetic information to better predict drug response in its pediatric patients. By understanding how a child’s genetic profile may affect drug response, providers can choose safer and more effective medications for patients.

Nemours has integrated ActX Genomic Decision Support within Epic, used in the care of nearly half a million children annually throughout the nation’s only multi-state children’s health system. This integration brings pharmacogenomics to the point of care by enabling real-time checking of each prescription order against the patient’s pharmacogenomic profile. Prescribing providers will be alerted if a drug may be ineffective, may cause an adverse reaction, or requires a dosing change based on the patient’s genetic information, all within the normal prescribing workflow. The initial pharmacogenomic panel at Nemours includes pharmacogenes related to commonly used medications such as certain antidepressants, opioids, and nonsteroidal anti-inflammatory drugs, or NSAIDs.

“Choosing the right medication at the right dose is extremely important for children,” said Pamela H. Arn, MD, Medical Director of Precision Medicine. “Clinical decision support provided by ActX will allow us to apply pharmacogenomic results alongside clinical information to arrive at the best medication and dose for the patient.”

The new platform was initiated at Nemours/Alfred I. duPont Hospital for Children in Wilmington, DE. Over the coming months, the service will continue to develop across the Nemours enterprise with goals to first expand the scope of practice in the Delaware Valley, then to expand to Jacksonville and Orlando, FL by early 2021. The pharmacogenomics service will also allow for unique research opportunities and collaboration.

“We are excited to partner with Nemours to bring precision medicine and pharmacogenomic decision support into pediatric care,” said Dr. Andrew Ury, CEO of ActX. “The ActX platform will help make actionable pharmacogenomics practical for Nemours’ physicians and their patients.”

Nemours’ implementation of ActX within Epic marks a big step toward making precision medicine the norm for its patients.

About ActX

ActX helps physicians make better decisions about medical treatment, using patients’ genetic information. ActX uses its GenoACT℠ clinical decision support program to analyze a patient’s genetic information and alert physicians in real time through their existing workflow tools about drug-genome interactions, actionable hereditary risks and carrier status. For more information, info@actx.com or (888) 998-2289.

About Nemours

Nemours is an internationally recognized children’s health system that owns and operates two free-standing children’s hospitals: Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children’s Hospital in Orlando, Fla., along with outpatient facilities in five states, delivering pediatric primary, specialty and urgent care. Nemours also powers the world’s most-visited website for information on the health of children and teens, KidsHealth.org, and offers on-demand, online video patient visits through Nemours CareConnect. Nemours ReadingBrightstart.org is a program dedicated to preventing reading failure in young children, grounded in Nemours’ understanding that child health and learning are inextricably linked, and that reading level is a strong predictor of adult health.

Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours provides pediatric clinical care, research, education, advocacy and prevention programs to families in the communities it serves.

Share article on social media or email:

Spero Clinic to Share How They Help Patients with CRPS at the Treating the Whole Person: Optimizing Wellness Virtual Conference


Treating the Whole Person: Optimizing Wellness Virtual Conference - CRPS Spero Clinic

The Spero Clinic, operated by Dr. Katinka van der Merwe, is joining a virtual seminar at the Treating the Whole Person: Optimizing Wellness Conference on Thursday, October 22, 2020. The conference, which is free, starts at 7pm EST. Dr. Katinka and Dr. Hannelie van der Merwe are excited to share their common findings and novel approach with the CRPS community.

People from all walks of life who suffer from CRPS can register for the conference, which is hosted by the Reflex Sympathetic Dystrophy Syndrome Association (RSDSA), an organization with the goal of helping chronic pain sufferers become pain-free by using holistic techniques. The conference begins on October 19th and runs through the 22nd.

The Spero Clinic specializes in using holistic, non-invasive procedures in order to help people with CRPS (standard or type one), Ehlers-Danlos Syndrome, and other chronic pain and neurologic disorders. Some of the many procedures that they perform include nerve adjustments, magnetic resonance treatments, oxygen therapy, scar tissue therapy, and ionic purification. The clinic employs a number of specialists who have one goal in mind – to help their patients live a pain-free life without having to resort to invasive procedures, prescription medications, or traditional pain management methods.

CRPS causes chronic pain that people suffer from and have to deal with on a daily basis. The syndrome is caused by damage to the central or peripheral nervous system. Malfunctions of the nervous system can cause CRPS as well. The nervous system runs from the brain throughout the entire body, where it is responsible for sending and interpreting the brain’s signals.

Dr. Katinka, the daughter of a chiropractor, grew up in South Africa. She later attended the Parker College of Chiropractic in Dallas, Texas before opening the Spero Clinic with the goal of not only following in her father’s footsteps but also helping people address their pain levels. She has written two books on the subject, Taming the Beast: A Guide to Conquering Fibromyalgia and Putting Out the Fire: New Hope for RSD/CRPS.

Her sister, Dr. Hannelie is also a chiropractor, and she has studied functional neurology and understands that many blood conditions, like urinary tract infections and the Epstein Barr Virus tend to make it tough for patients to recover from the conditions that cause their chronic pain. She runs the Spero Clinic’s laboratory where she spends her days examining patient’s bloodwork in order to detect any abnormalities.

Both will be speaking during their conference session on October 22nd. The Treating the Whole Person: Optimizing Wellness Conference also includes several virtual networking and expo hall sessions, as well as presentations on topics like Should Physical Therapy Hurt and A Holistic Approach to CRPS.

For more information or to register for the conference, please see the event website at https://hopin.to/events/rsdsa2020b or visit the Spero Clinic Facebook page.

More About Spero Clinic

At the Spero Clinic, Dr. Katinka van der Merwe and her team use a Neurologic Recovery Program to help patients who are suffering from severe chronic pain like RSD/CRPS. They focus on Neurologic Rehabilitation and restoring balance to the Autonomic Nervous System. Dr. Katinka’s world leading 12 Week Neurologic Rehabilitation program helps treat hopeless cases worldwide.

For more information, please visit https://www.thesperoclinic.com or call (479) 304-8202.

Share article on social media or email:

Gini Health Announces First Dynamic Multivitamin Powered by Health Tracker Data Including New Integrations with MyFitnessPal and Others


Gini Health Logo

Gini Health is changing the status quo of the one-size-fits-all approach to nutrition and vitamin supplements through technology and data-driven personalization.

Since we get vitamins naturally from the foods we eat—and most should come from food—the only true way to customize vitamins and prevent overnutrition is by taking food intake into account.

Gini Health, a Techstars startup with a health and wellness tracking app that supports continuously hyper-customized smart vitamins, today announced it has integrated with MyFitnessPal—among many other health trackers—to create vitamins that fill in dietary gaps. Gini Health is on a mission to motivate consumers to get most of their vitamins from real food and prevent overnutrition. And, since these vitamins are Canadian made, they’re regulated by the federal government, unlike the U.S.

Overnutrition, the less-talked-about but still dangerous side of malnutrition, is increasing as people spend more time at home, focused on their health and trying to build immunity against COVID-19.

“The popular belief is that vitamins are…just vitamins, so they can’t do any harm. A riskier belief is that if some vitamins are good, then more must be better,” said Gurjot Narwal, Gini Health founder and CEO. ”Vitamin companies make more money when you purchase more vitamins, so it’s not surprising that these have become the prevailing views in society.”

Unlike other custom vitamin companies that ask customers to take a simplistic 1-minute quiz, Gini Health combines its users’ health data from fitness trackers like the Apple Watch, apps like MyFitnessPal, and even DNA tests from 23andMe and others. Every formulation of Gini Smart Vitamins is unique, and identical twin sisters would still see different ingredients. In addition, this formulation comes as just one or two capsules. Other companies typically send their customers handfuls of vitamins.

“Since we get vitamins naturally from the foods we eat—and most should come from food—the only true way to customize vitamins and prevent overnutrition is by taking food intake into account,” added Narwal. “Gini Health’s new integration with MyFitnessPal and all major nutrition trackers, including Apple Health, Google Fit, Fitbit and Oura ring, helps us do just that.”

Gini Health offers the most customized vitamins on the market by taking into consideration a combination of genetic risks, current health, health goals and food intake—and on an ongoing basis, users can track lifestyle changes (such as spending more time indoors, requiring more Vitamin D) and health data such as sleep, diet and even their poop—creating a continuous personalization.

About Gini Health

Gini Health is changing the status quo of the one-size-fits-all approach to nutrition and vitamin supplements through technology and data-driven personalization. The company’s mission is to reduce its customers’ reliance on supplements and push them toward better dietary choices. It is the first and only smart vitamin solution that has a dynamically-changing multivitamin formula that adjusts to the individual’s lifestyle. This is built upon the solid base of genetic data, current health status and health goals along with lifestyle data like diet, sleep and exercise to provide personalized nutrition targets and supplement plans to address health and nutrition in a holistic way. For more information, visit ginihealth.com. Gini Health’s press kit is available here.

Share article on social media or email:

Anthony P. Castore, CEO, Ziering Medical Group Appointed to Aesthetic Industry Association Advisory Board


“Anthony has been a great addition to our team, making significant contributions to the advancement of our organization, and I am pleased he will represent Ziering Medical in the industry, bringing his exceptional skills and business development support to elevate the industry” Dr. Craig Ziering

Anthony P. Castore, CEO of Ziering Medical, the leader in hair restoration in the United States, has been appointed to the Aesthetic Industry Association [AIA] advisory board. Mr. Castore is a seasoned business expert with a solid reputation for implementing programs, protocols, business development strategies and efficiencies for profitability accelerating growth and scaling elective medical practices. He has also been published in Inc. magazine and serves as a medical faculty advisor for the AMspa Medical Spa Show. In his role, Mr. Castore will work with an illustrious group of industry executives to guide and advise AIA in their broad-based efforts to support development, sustainability, and other active business interests of its global aesthetics membership, serving highly-motivated rejuvenation and advanced cosmetic consumers across all demographics.

“We are proud to announce that Anthony Castore, CEO of the prestigious Ziering Medical hair-restoration clinics, has joined the Industry Advisory Board of the Aesthetic Industry Association (AIA)”, shared Michael Moretti, Executive Director and Founder of the AIA. After extensive interviews and professional references, we realized that Anthony is a very talented clinic operator who understands how to scale large aesthetic practices quickly to optimize potential while increasing profitability. The AIA will benefit greatly from his operational expertise.”

Under Mr. Castore’s leadership, Ziering Medical has experienced significant growth over the past two years. Instrumental in streamlining operational efficiencies, client capture, conversion and developing an effective digital footprint and retail expansion, he has also proven adept at crucial reactivity to industry changes and anticipating needs. “I am excited to have this opportunity to share the knowledge and experience I have building solid business foundations, addressing critical market issues and opportunities as well as forward thinking strategies to AIA members to create pathways for improved proficiencies, performance and profitability in their practices and the aesthetic industry as a whole”.

In collaboration with Dr. Ziering, a pioneer in hair transplantation leadership, technology and education, Mr. Castore developed the practice teleconsulting, marketing and service offerings to keep the highly personalized Ziering practice, healthy and stable with continued growth during this Covid-19 period across all locations. Dr. Ziering, who established his renowned Ziering Medical Group and brand in 2003 encompassing sought after surgical procedures, non-invasive technologies, home care treatments, topical treatments and supplements, was the first doctor to showcase hair transplantation services in his televised role on Extreme Makeover.

Benefiting from business strategy, support and synergies with Mr. Castore for exemplary growth, he continues to teach his signature services and protocols to medical professionals globally, and is an editorial contributor to Sandow Media’s New Beauty Magazine quarterly as well as writing peer reviewed articles in dozens of publications on the topic of hair restoration and transplantation. According to Dr. Craig Ziering, “Anthony has been a great addition to our team. He has made significant contributions to the advancement of our organization, and I am pleased he will represent Ziering Medical in the industry, bringing his exceptional skills in long term planning and business development support to elevate the industry and thousands of AIA members.”

As part of his role, Mr. Castore, will be a featured speaker on an expert panel during the October 30th AIA Board meeting on the topic of Branding Aesthetics Practices & Corporate Recovery from the Pandemic as well as have leadership role in industry meetings and advisory as well as engagements at forums, panels, virtual events and trade shows throughout 2021.

About The Aesthetic Industry Association (AIA): Medical Insight (MII) founded the AIA in 2019. The Aesthetic Industry Association (AIA) is the first and only member-driven organization dedicated to the long-term planning and development of the $14 Billion medical aesthetic industry and its hundreds of suppliers, thousands of executives and providers, working to ensure a bright and successful future.

About Medical Insights (MII): For the past 25 years Medical Insight has provided the benchmark market research data and metrics charting the continuous growth of medical aesthetics across the globe. MII also published the only news magazines focused on related clinical and corporate news from each major geographical region. And THE Aesthetic Show, developed and produced by MII, has become the largest truly multi-specialty conference in North America.

About Ziering Medical: Founded in 2003 by Dr. Craig Ziering, a global leader in hair restoration, Ziering Medical is a multi-dimensional and fully comprehensive hair restoration practice combining state-of-the-art hair transplant procedures and hair regeneration therapies with highly personalized treatment programs to manage the progressive nature of hair loss. Dr. Ziering serves as Medical Director to four locations in Beverly Hills and Newport Beach, CA, Las Vegas, NV, Greenwich, CT, and a newly renovated flagship surgery center in New York City. Ziering Medical offers services for male and female pattern baldness as well as expertise in African American hair, transgender hairline modification, beard and eyebrow restoration, using many techniques pioneered by Dr. Ziering. Understanding each patient’s unique hair restoration journey, both Follicular Unit Strip Surgery (FUSS) and Follicular Unit Excision and Extraction (FUE) are performed by Ziering surgeons, allowing for truly customized, personal treatment plans. Taking a distinctive lifestyle approach, Ziering Medical provides a full array of non-surgical treatments and at-home care, including the Ziering LaserCap, Zmin and Zfin, [specially formulated topical minoxidil and finasteride, respectively]. Stem cell scalp injection treatments with Amnio Z and Exosomes and lasers are all designed to meet the long term strategies and patient population needs. The first branded product line, a specialty hair loss shampoo and conditioner, formulated by Dr. Ziering, called Zrx Follicle Cleanse and Zrx Follicle Sustenance, will be available in early 2021.

https://twitter.com/ziering_medical?lang=en

https://twitter.com/craigziering?lang=en

https://www.facebook.com/DrZiering

https://www.facebook.com/ZieringMedical/

https://www.instagram.com/dr.craigziering/?hl=en

https://www.instagram.com/zieringmedical/?hl=en

Share article on social media or email: